These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 23932534

  • 1. Safety of electroconvulsive therapy in patients receiving dabigatran therapy.
    Schmidt ST, Lapid MI, Sundsted KK, Cunningham JL, Ryan DA, Burton MC.
    Psychosomatics; 2014; 55(4):400-403. PubMed ID: 23932534
    [No Abstract] [Full Text] [Related]

  • 2. [Modern Approaches to Prevention of Thromboembolic Complications in Patients With Nonvalvular Atrial Fibrillation With a Direct Thrombin Inhibitor Dabigatran].
    Savina NM.
    Kardiologiia; 2016 Jul; 56(7):91-99. PubMed ID: 28290913
    [Abstract] [Full Text] [Related]

  • 3. Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis.
    Phan K, Wang N, Pison L, Kumar N, Hitos K, Thomas SP.
    Int J Cardiol; 2015 Apr 15; 185():209-13. PubMed ID: 25797679
    [No Abstract] [Full Text] [Related]

  • 4. Antithrombotic therapy: Dual therapy after PCI in AF.
    Lim GB.
    Nat Rev Cardiol; 2017 Nov 15; 14(11):634. PubMed ID: 28905864
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G, Blotière PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, Zureik M.
    Circulation; 2015 Sep 29; 132(13):1252-60. PubMed ID: 26199338
    [Abstract] [Full Text] [Related]

  • 6. Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals.
    Perram J, Joseph J, Holloway C.
    BMJ Case Rep; 2015 Nov 20; 2015():. PubMed ID: 26590187
    [Abstract] [Full Text] [Related]

  • 7. Identification and management of noncompliance in atrial fibrillation patients receiving dabigatran: the role of a drug monitor.
    Hu YF, Liao JN, Chern CM, Weng CH, Lin YJ, Chang SL, Wu CH, Sung SH, Wang KL, Lu TM, Chao TF, Lo LW, Chung FP, Hsu LC, Chen SA.
    Pacing Clin Electrophysiol; 2015 Apr 20; 38(4):465-71. PubMed ID: 25601592
    [Abstract] [Full Text] [Related]

  • 8. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A, Baranchuk A, Redfearn D, Simpson C, Abdollah H, Michael K.
    Expert Rev Cardiovasc Ther; 2015 May 20; 13(5):529-40. PubMed ID: 25843430
    [Abstract] [Full Text] [Related]

  • 9. Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
    Pallisgaard JL, Lindhardt TB, Hansen ML, Schjerning AM, Olesen JB, Staerk L, Torp-Pedersen C, Gislason GH.
    PLoS One; 2015 May 20; 10(10):e0141377. PubMed ID: 26513589
    [Abstract] [Full Text] [Related]

  • 10. Depressive symptoms associated with dabigatran: a case report.
    Eryilmaz G, Enez Darcin A, Saglam E, Gogcegoz Gul I.
    Psychogeriatrics; 2015 Sep 20; 15(3):209-11. PubMed ID: 25515766
    [Abstract] [Full Text] [Related]

  • 11. Uninterrupted dabigatran for ablation in atrial fibrillation: Peering into the black box of intra-procedural anticoagulation.
    Martin AC, Godier A.
    Anaesth Crit Care Pain Med; 2018 Aug 20; 37(4):375. PubMed ID: 28939467
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P, Duraj I, Szlagowska L, Ciastkowska A, Broncel M.
    Pol Merkur Lekarski; 2014 Nov 20; 37(221):261-4. PubMed ID: 25546985
    [Abstract] [Full Text] [Related]

  • 13. Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question.
    Sunbul M, Cincin A, Mammadov C, Mutlu B.
    Am J Ther; 2016 Nov 20; 23(3):e974-6. PubMed ID: 25415546
    [Abstract] [Full Text] [Related]

  • 14. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.
    Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Pilote L.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 20; 8(6):593-9. PubMed ID: 26508666
    [Abstract] [Full Text] [Related]

  • 15. Adherence in patients with atrial fibrillation treated with dabigatran.
    Grześk G, Janiszewska E, Malinowski B, Kubica A, Wiciński M.
    Kardiol Pol; 2018 Nov 20; 76(11):1562-1563. PubMed ID: 30211436
    [No Abstract] [Full Text] [Related]

  • 16. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov 20; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous hemothorax due to dabigatran use in a patient with atrial fibrillation.
    Akgedik R, Günaydin Z, Bektas O, Karagöz A, Öztürk H.
    Clin Respir J; 2017 May 20; 11(3):394-396. PubMed ID: 26083004
    [No Abstract] [Full Text] [Related]

  • 18. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Noseworthy PA, Yao X, Abraham NS, Sangaralingham LR, McBane RD, Shah ND.
    Chest; 2016 Dec 20; 150(6):1302-1312. PubMed ID: 27938741
    [Abstract] [Full Text] [Related]

  • 19. Dabigatran (Pradaxa(®)): surgeon's friend or foe?
    Syyed N, Ansell M, Sood V.
    Br Dent J; 2014 Dec 05; 217(11):623-6. PubMed ID: 25476635
    [Abstract] [Full Text] [Related]

  • 20. Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?
    Hoepner R, Behrendt V, Meves S, Gold R, Krogias C.
    Neurologist; 2015 Jul 05; 20(1):1-3. PubMed ID: 26185953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.